Shuai Su
No.1095 Jie Fang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma.
Journal: Stem cell reviews and reports
Published: July 15, 2026
Current status and progress in the diagnosis and treatment of monomorphic epitheliotropic intestinal T-cell lymphoma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 06, 2026
Case of Myelodysplastic Syndrome 15 Years After Kidney Transplantation Under Long-Term Immunosuppression.
Journal: Case reports in hematology
Published: March 09, 2026
MEF2A activates the ZDHHC20/NF-κB pathway to inhibit doxorubicin sensitivity and promote the malignant progression of acute myeloid leukemia.
Journal: Biology direct
Published: January 12, 2026
Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis.
Journal: Cell biology and toxicology
Published: October 10, 2025
Prognostic value of BTG1 for predicting decitabine sensitivity in de novo acute myeloid leukemia.
Journal: iScience
Published: August 21, 2025
DIA Regimen Versus IA Regimen for Induction Therapy in Younger Adults With Acute Myeloid Leukemia: A Multicenter Open-Label Randomized Controlled Trial.
Journal: American journal of hematology
Published: July 12, 2025
Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma.
Journal: Frontiers in pharmacology
Published: May 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026